{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-000866","form_type":"8-K","ticker":"XBIO","cik":"0001534525","company_name":"Xenetic Biosciences, Inc.","filed_at":"2024-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.534357+00:00","generated_at":"2026-06-06T04:17:30.113937+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Xenetic Biosciences posts investor video by CSO on DNase I oncology preclinical data","bullets":["Chief Scientific Officer Curis Lockshin, PhD, discusses preclinical data from DNase I oncology platform.","Video available at https://www.virtualinvestorco.com/wtm-xbio-8k.","No financial results, guidance, or material business changes disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-000866","json":"https://secwatch.observer/filing/0001683168-24-000866.json","markdown":"https://secwatch.observer/filing/0001683168-24-000866.md","text":"https://secwatch.observer/filing/0001683168-24-000866.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534525/000168316824000866/0001683168-24-000866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534525/000168316824000866/xenetic_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T04:17:30.113937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}